These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
997 related articles for article (PubMed ID: 30548308)
1. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p. Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308 [TBL] [Abstract][Full Text] [Related]
2. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5. Ye F; Tian L; Zhou Q; Feng D Gene; 2019 Dec; 721():144093. PubMed ID: 31473323 [TBL] [Abstract][Full Text] [Related]
3. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142. Zhang L; Zhao G; Ji S; Yuan Q; Zhou H Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma. Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190 [TBL] [Abstract][Full Text] [Related]
5. LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway. Tong CJ; Deng QC; Ou DJ; Long X; Liu H; Huang K Aging (Albany NY); 2021 May; 13(16):20116-20130. PubMed ID: 34048366 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223. Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217 [TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA OIP5-AS1 Contributes to the Progression of Atherosclerosis by Targeting miR-26a-5p Through the AKT/NF-κB Pathway. Ren M; Wang T; Han Z; Fu P; Liu Z; Ouyang C J Cardiovasc Pharmacol; 2020 Nov; 76(5):635-644. PubMed ID: 32833899 [TBL] [Abstract][Full Text] [Related]
8. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway. Ma X; Ren H; Zhang Y; Wang B; Ma H Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene. Li KW; Wang SH; Wei X; Hou YZ; Li ZH Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis. Liu ZB; Wang JA; Lv RQ Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262 [TBL] [Abstract][Full Text] [Related]
11. Circular RNA circ-CHI3L1.2 modulates cisplatin resistance of osteosarcoma cells via the miR-340-5p/LPAATβ axis. Zhang Z; Zhou Q; Luo F; Zhou R; Xu J; Xiao J; Dai F; Song L Hum Cell; 2021 Sep; 34(5):1558-1568. PubMed ID: 34164774 [TBL] [Abstract][Full Text] [Related]
12. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway. Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA TMPO-AS1/miR-126-5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway. Hu Y; Zhang Y; Ding M; Xu R J Gastroenterol Hepatol; 2021 Jul; 36(7):1877-1888. PubMed ID: 33295056 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer. Ma T; Chen H; Wang P; Yang N; Bao J Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162 [No Abstract] [Full Text] [Related]
15. Molecular mechanism of miR-34b-5p and RNA binding protein HuR binding to lncRNA OIP5-AS1 in colon cancer cells. Wang Y; Lin C; Liu Y Cancer Gene Ther; 2022 May; 29(5):612-624. PubMed ID: 34021273 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway. Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway. Meng X; Ma J; Wang B; Wu X; Liu Z J Physiol Biochem; 2020 May; 76(2):301-315. PubMed ID: 32157498 [TBL] [Abstract][Full Text] [Related]
18. Silencing LPAATβ inhibits tumor growth of cisplatin-resistant human osteosarcoma in vivo and in vitro. Song L; Duan P; Gan Y; Li P; Zhao C; Xu J; Zhang Z; Zhou Q Int J Oncol; 2017 Feb; 50(2):535-544. PubMed ID: 28035350 [TBL] [Abstract][Full Text] [Related]
19. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling. Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma. Zhao G; Cai C; Yang T; Qiu X; Liao B; Li W; Ji Z; Zhao J; Zhao H; Guo M; Ma Q; Xiao C; Fan Q; Ma B PLoS One; 2013; 8(1):e53906. PubMed ID: 23372675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]